Double-blind, Placebo-controlled, Randomised Withdrawal, Extension, Safety and Efficacy Study of LDX in Children and Adolescents Aged 6-17



Status:Archived
Conditions:Neurology, Psychiatric
Therapuetic Areas:Neurology, Psychiatry / Psychology
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:January 2009
End Date:August 2011

Use our guide to learn which trials are right for you!

A Phase III, Double-blind, Placebo-controlled, Randomised Withdrawal, Multicentre, Extension, Safety and Efficacy Study of Lisdexamfetamine Dimesylate (LDX) in Children and Adolescents Aged 6-17 With Attention- Deficit/Hyperactivity Disorder (ADHD)


The main aim of this study is to evaluate the long-term maintenance of efficacy of LDX after
administered to children and adolescents aged 6-17 with ADHD for at least 6 months



We found this trial at
4
sites
Overland Park, Kansas 23112
?
mi
from
Overland Park, KS
Click here to add this to my saved trials
6141 Sunset Dr # 301
South Miami, Florida 33143
(305) 598-3125
Miami Research Associates Miami Research Associates (MRA) is the largest privately-owned multi-specialty clinical research center...
?
mi
from
South Miami, FL
Click here to add this to my saved trials
Orlando, Florida 32806
?
mi
from
Orlando, FL
Click here to add this to my saved trials
Rolling Hills Estates, California 66212
?
mi
from
Rolling Hills Estates, CA
Click here to add this to my saved trials